Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 病理學科所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/50611
標題: CRISPR/Cas9系統在肝癌研究之應用
Applications of CRISPR/Cas9 System in Liver Cancer Research
作者: Shih-Yao Peng
彭詩窈
指導教授: 鄭永銘(Yung-Ming Jeng)
關鍵字: CRISPR/Cas9,library screen,染色體轉位,FGFR2,BICC1,
CRISPR/Cas9,library screen,chromosomal translocation,FGFR2,BICC1,
出版年 : 2016
學位: 碩士
摘要: Clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins system (CRISPR/Cas9 system) is a highly efficient genome editing tool. It consists of two components: a strand of ribonucleic acid called small guide RNA (sgRNA) and an enzyme called CRISPR-associated endonuclease 9 (Cas9). In this system, sgRNA directs Cas9 to a targeted DNA sequence for site-specific cleavage. Recently, the mutagenic function of CRISPR/Cas9 system is widely used in genome and cancer researches. In this study, we exploited CRISPR/Cas9 system in two topics: CRISPR/Cas9 library screening in live cancer cell line and CRISPR/Cas9-mediated chromosomal translocation between Fibroblast growth factor receptor 2 (FGFR2) gene and BicC Family RNA Binding Protein 1 (BICC1) gene. In CRISPR/Cas9 library screen, we used HepG2 cell line to produce a mixture of cells with loss-of-function mutations of genes and then made tumor formation in NOD/SCID mice by subcutaneous injection of those cells. According to the consequences of next-generation sequencing, we found that some populations of CRISPR/Cas9 knockout cells dominated in quantity in late-phase tumors, so the possible explanation is that those genes knockout by the CRISPR/Cas9 system are suppressor of tumor progression. Further experiment revealed that one of the genes identified, DEDD2, can inhibit cell death caused by oxidative stress. In CRISPR/Cas9-mediated chromosomal translocation study, we used BICC1 and FGFR2-targeting CRISPR/Cas9 plasmids to produce the predicted FGFR2-BICC1 fusion DNA products. Although this method worked, the output was low. As a result, we developed the two-target CRISPR/Cas9 plasmids to improve the efficiency by increasing the possibility of cleavage of two target genes in one single cell. However, the experiment results showed that those plasmids were unable to produce the predicted chromosomal translocation products.
URI: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/50611
DOI: 10.6342/NTU201601097
全文授權: 有償授權
顯示於系所單位:病理學科所

文件中的檔案:
檔案 大小格式 
ntu-105-1.pdf
  目前未授權公開取用
2.66 MBAdobe PDF
顯示文件完整紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved